Related Companies
|
[]
|
||||||||
Related Funds
|
[]
|
||||||||
|
|||||||||
English
|
|||||||||
oda_MaterialEventDisclosureGeneralAbstract|
|
|
||||||||
oda_UpdateAnnouncementFlag|
|
|
Hayır (No)
|
|||||||
oda_CorrectionAnnouncementFlag|
|
|
Hayır (No)
|
|||||||
oda_DateOfThePreviousNotificationAboutTheSameSubject|
|
|
31.07.2025
|
|||||||
oda_DelayedAnnouncementFlag|
|
|
Hayır (No)
|
|||||||
oda_AnnouncementContentSection|
|
|
||||||||
oda_ExplanationSection|
|
|
||||||||
oda_ExplanationTextBlock|
|
Our shareholder Lightyear Healthcare BV ("Lightyear") and FOM Grup Mimarlık İnşaat ve Ticaret A.Ş. have provided the following information to our Company:
As stated in the announcement titled "Regarding the Share Sale Transactions to be Carried Out by Lightyear Healthcare BV" dated July 31, 2025, A Group shares with a nominal value of TL 18,179,104, corresponding to 9.5% of MPARK's issued capital and owned by Lightyear, have been sold to FOM Grup Mimarlık İnşaat ve Ticaret A.Ş. ("FOM"). The per share transfer price used in this transaction is equal to the per share sale price determined in the accelerated bookbuilding process.
As a result of the above-mentioned transaction, Lightyear's shareholding in MPARK became 15.1%, and FOM's shareholding in MPARK became 9.5%.
FOM's shareholding in MPARK will increase to 10,6% through the purchase of other A Group shares owned by Lightyear by September 15, 2025.
All remaining A Group shares held by Lightyear will be purchased by FOM by September 30, 2026 following the share transfers to be made until September 15, 2025.
|